ANTICOV: Clinical trial for COVID-19 in low-r
KINSHASA /ย NAIROBI /ย GENEVAย โย 10ย Februaryย 2022ย โย The ANTICOV platform clinical trialย has startedย the recruitment of participants to testย a newย promisingย drug combination, fluoxetineย andย budesonide,ย as an early treatment for peopleย affected with mild-to-moderate COVID-19. Theย ANTICOV trial, currently conducted in 13 […]
ANTICOV: Clinical trial for COVID-19 in low-r Read More ยป


















